QPS Austria (part of QPS Holdings) is a full-service contract research organization (CRO) providing preclinical as well as clinical research services.
About QPS Neuropharmacology
The portfolio of our preclinical Neuropharmacology group covers various validated transgenic and non-transgenic in vivo and in vitro models for neurodegeneration such as AD, PD, for orphan diseases including HD and ALS , for lipid storage disease and dyslipidemia, and for diseases like psychosis, anxiety, schizophrenia, or autism.
While many of our models are solely available at QPS Neuropharmacology, all of them are well characterized in house and published in peer reviewed high impact journals. Besides in vivo research we also offer biochemical and histological analyses. To support our clients in the best possible way, we use or adapt existing models, or establish new models specific to your research focus.
- 750m² (>8,000 sq ft) animal facility
- 9 rooms for animal housing equipped with IVCs
- 7 rooms for the performance of behavioral research equipped with state of the art instruments
- Up to date animal housing and hygienic equipment as well as facility layout to ensure efficient accomplishment of in vivo projects
- Biosafety level 1 and 2 laboratories
- Automated cell and tissue culture image processing hard and software
- Cutting edge evaluation equipment
- Fully equipped histology laboratories for all fixation, tissue processing, sectioning and staining
- Modern image capture equipment
- State of the art image processing hard- and software
- Protein-biochemistry laboratories outfitted for cutting edge techniques incl. aggregation studies
- State of the art equipment for biochemical determinations (fluorometry, densitometry…) including biomarker evaluations (MSD imager and others)